Director/PDMR Shareholding

Summary by AI BETAClose X

Hill & Smith PLC announced that on May 26, 2026, Chief Financial Officer Chris McLeish exercised his 2023 Deferred Bonus Buy-Out Award, acquiring 5,690 ordinary shares at nil cost. Subsequently, he sold 2,682 of these ordinary shares for £27.60 each on the XLON trading venue to cover associated tax and National Insurance liabilities.

Disclaimer*

Hill & Smith PLC
27 May 2026
 

 

Hill & Smith PLC

(the 'Company' or 'Hill & Smith')

 

Director / PDMR Shareholding

 

Hill & Smith announces that on 26 May 2026, it was notified of the exercise and subsequent sale by Chris McLeish, Chief Financial Officer of Shares under his 2023 Deferred Bonus Buy-Out Award.

 

The Notification of Dealing Form can be found below:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Chris McLeish

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Acquisition of Ordinary Shares pursuant to the exercise of an award under his 2023 Deferred Bonus Buy-Out Award.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)



Nil

 

5,690

(e)

Aggregated information

N/A

- Aggregated volume


- Price


(f)

Date of the transaction

26 May 2026

(g)

Place of the transaction

Outside of a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Sale of Ordinary Shares to cover tax and NI liability on the exercise of awards outlined in 4.1.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)



£27.60

 

2,682

(e)

Aggregated information

N/A

- Aggregated volume


- Price


(f)

Date of the transaction

26 May 2026

(g)

Place of the transaction

XLON

 

Enquiries:

 

Karen Atterbury

Company Secretary

0121 704 7430

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings